BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30379233)

  • 1. Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin.
    Mello AGNC; Vieira MVDF; Sena LWP; Paixão TPD; Pinto ACG; Grisólia DPA; Silva MT; Vieira JLF
    Rev Inst Med Trop Sao Paulo; 2018 Oct; 60():e66. PubMed ID: 30379233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
    Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
    Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of primaquine and carboxyprimaquine concentrations in plasma and blood cells in Plasmodium vivax malaria cases following chronic dosage with primaquine.
    Dua VK; Kar PK; Sarin R; Sharma VP
    J Chromatogr B Biomed Appl; 1996 Jan; 675(1):93-8. PubMed ID: 8634775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.
    Kim YR; Kuh HJ; Kim MY; Kim YS; Chung WC; Kim SI; Kang MW
    Arch Pharm Res; 2004 May; 27(5):576-80. PubMed ID: 15202566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent of chloroquine underdosing in adult patients with malaria by Plasmodium vivax from an endemic area of the Brazilian Amazon basin.
    Valéria Dias Ferreira M; Gabryelle Nunes Cardoso Mello A; Sena LWP; Regina Matos Lopes T; Luiz Fernandes Vieira J
    Trop Med Int Health; 2020 Sep; 25(9):1093-1097. PubMed ID: 32633099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors.
    Gomes Mdo S; Vieira JL; Machado RL; Nacher M; Stefani A; Musset L; Legrand E; Menezes RA; Júnior AA; Sousa AP; Couto VS; Couto ÁA
    Malar J; 2015 Oct; 14():402. PubMed ID: 26453152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doses of primaquine administered to children with
    Vieira MVDF; Matos Lopes TR; Mello AGNC; de Sena LWP; Commons RJ; Vieira JLF
    Pathog Glob Health; 2020 Oct; 114(7):388-392. PubMed ID: 32705964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.
    Pereira D; Daher A; Zanini G; Maia I; Fonseca L; Pitta L; Ruffato R; Marchesini P; Fontes CJ
    Malar J; 2016 Sep; 15():477. PubMed ID: 27639847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria.
    Chu CS; Watson JA; Phyo AP; Win HH; Yotyingaphiram W; Thinraow S; Soe NL; Aung AA; Wilaisrisak P; Kraft K; Imwong M; Hanpithakpong W; Blessborn D; Tarning J; Proux S; Ling C; Nosten FH; White NJ
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0130221. PubMed ID: 34398667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin.
    de Sena LWP; Mello AGNC; Ferreira MVD; de Ataide MA; Dias RM; Vieira JLF
    Malar J; 2019 Dec; 18(1):439. PubMed ID: 31864358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.
    Villalobos-Salcedo JM; Tada MS; Kimura E; Menezes MJ; Pereira da Silva LH
    Ann Trop Med Parasitol; 2000 Dec; 94(8):749-58. PubMed ID: 11214093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interactions between primaquine and chloroquine.
    Pukrittayakamee S; Tarning J; Jittamala P; Charunwatthana P; Lawpoolsri S; Lee SJ; Hanpithakpong W; Hanboonkunupakarn B; Day NP; Ashley EA; White NJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3354-9. PubMed ID: 24687509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
    Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections.
    Gogtay NJ; Desai S; Kamtekar KD; Kadam VS; Dalvi SS; Kshirsagar NA
    Ann Trop Med Parasitol; 1999 Dec; 93(8):809-12. PubMed ID: 10715673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria.
    Duarte EC; Pang LW; Ribeiro LC; Fontes CJ
    Am J Trop Med Hyg; 2001 Nov; 65(5):471-6. PubMed ID: 11716100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures.
    Gilder ME; Hanpithakphong W; Hoglund RM; Tarning J; Win HH; Hilda N; Chu CS; Bancone G; Carrara VI; Singhasivanon P; White NJ; Nosten F; McGready R
    Clin Infect Dis; 2018 Sep; 67(7):1000-1007. PubMed ID: 29590311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.